XAS applied to pharmaceuticals:: drug administration and bioavailability

被引:24
作者
Nicolis, I
Deschamps, P
Curis, E
Corriol, O
Acar, V
Zerrouk, N
Chaumeil, JC
Guyon, F
Bénazeth, S
机构
[1] Univ Paris 05, Fac Pharm, Lab Biomath, F-75270 Paris 6, France
[2] Univ Paris 05, Fac Pharm, Pharm Galen Lab, F-75270 Paris, France
[3] Ctr Univ Paris Sud, LURE, F-91405 Orsay, France
[4] Hop Necker Enfants Malad, Serv Pharmaceut, F-75730 Paris 15, France
[5] Pharm Cent Hop Paris, Serv Rech & Dev, F-75005 Paris, France
[6] Univ Paris 05, Fac Pharm, Chim Analyt Lab, F-75270 Paris 6, France
关键词
XAS; pharmaceutical; parenteral nutrition; Menkes disease; leukaemia; zinc; copper; arsenic;
D O I
10.1107/S0909049500017714
中图分类号
TH7 [仪器、仪表];
学科分类号
0804 ; 080401 ; 081102 ;
摘要
We present selected XAS applications, focused towards practical hospital questions of drug administration and bioavailability, where the technique is driven up to its limits of sensitivity. i) XAS was used to study the interactions between the components of parenteral nutrition solutions, in particular zinc and aminoacids, possibly modifying their bioavailability. ii) We studied by EXAFS a series of binary and ternary copperaminoacid complexes, in view of the development of an efficient oral drug against copper deficiencies in Menkes disease. iii) EXAFS and XANES analysis allowed us to characterise the solution form of a new arsenic containing drug against leukaemia. In parallel to the XAS measurements, we analysed trace elements levels along patients' hairs, using X-ray fluorescence excited by synchrotron radiation. The measurements along the hair allow for a monitoring of essential trace elements during therapy.
引用
收藏
页码:984 / 986
页数:3
相关论文
共 12 条
[1]  
ANGLADE P, 1990, NUTR CLIN METABOL, V4, P167
[2]   Quality control in hair analysis: A systematic study on washing procedures for trace element determinations [J].
Borella, P ;
Rovesti, S ;
Caselgrandi, E ;
Bargellini, A .
MIKROCHIMICA ACTA, 1996, 123 (1-4) :271-280
[3]   COPPER(II)-HISTIDINE STEREOCHEMISTRY - STRUCTURE OF L-HISTIDINATO-D-HISTIDINATODIAQUOCOPPER(II) TETRAHYDRATE [J].
CAMERMAN, N ;
FAWCETT, JK ;
KRUCK, TPA ;
SARKAR, B ;
CAMERMAN, A .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1978, 100 (09) :2690-2693
[4]  
Chen GQ, 1997, BLOOD, V89, P3345
[5]  
Chen X.M., 1994, J CHEM SOC DA, V15, P2331
[6]   Propagation of statistical errors across EXAFS extraction and Fourier filtering [J].
Curis, E ;
Bénazeth, S .
JOURNAL OF SYNCHROTRON RADIATION, 2000, 7 (04) :262-266
[7]  
KAIM W, 1994, BIOINORGANIC CHEM IN
[8]  
NICOLIS L, 2000, J TRACE MICROPROBE T, V18, P4
[9]   Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: Remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients [J].
Niu, C ;
Yan, H ;
Yu, T ;
Sun, HP ;
Liu, JX ;
Li, XS ;
Wu, W ;
Zhang, FQ ;
Chen, Y ;
Zhou, L ;
Li, JM ;
Zeng, XY ;
Yang, RRO ;
Yuan, MM ;
Ren, MY ;
Gu, FY ;
Cao, Q ;
Gu, BW ;
Su, XY ;
Chen, GQ ;
Xiong, SM ;
Zhang, TD ;
Waxman, S ;
Wang, ZY ;
Chen, Z ;
Hu, J ;
Shen, ZX ;
Chen, SJ .
BLOOD, 1999, 94 (10) :3315-3324
[10]  
SARKAR B, 1966, BIOCH COPPER